Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
Background: Many studies have explored the diagnostic performance of soluble suppression of tumorigenicity-2 (sST2) for heart failure (HF), but the results are inconsistent. Here, we performed a meta-analysis to assess the role of sST2 in the diagnosis of HF. Methods: We searched PubMed, Web of Scie...
Main Authors: | Dong-Hui Huang, Hao Sun, Jing-Pu Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2016-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=5;spage=570;epage=577;aulast=Huang |
Similar Items
-
Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure—A Prospective Observational Study
by: Victoria Dworok, et al.
Published: (2023-11-01) -
Soluble Suppression of Tumorigenicity‐2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device
by: Lieke Numan, et al.
Published: (2024-01-01) -
Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
by: Hasan A, et al.
Published: (2020-08-01) -
Predictive value of soluble suppression of tumorigenicity 2 in atrial fibrillation: a systematic review and meta-analysis
by: Pengfei Chen, et al.
Published: (2024-01-01) -
Soluble suppression of tumorigenicity 2 associated with atrial fibrillation detected after stroke: A retrospective study
by: Wenquan Hou, et al.
Published: (2023-11-01)